-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On April 23, Zhuhai Trinomab Biotech Co.
Technolab was established in December 2015 by the former Duke University Human Vaccine Research Director Dr.
According to the press release, this round of financing is mainly used for: 1) Clinical research of Tylenol Microlab natural human-derived respiratory syncytial virus monoclonal antibody TNM001, tetanus toxin monoclonal antibody TNM002, and nerve growth factor monoclonal antibody TNM009; 2) Preclinical research on other natural fully human monoclonal antibody drugs on the Tylenol Microlab pipeline, such as human cytomegalovirus, varicella-zoster virus, Staphylococcus aureus alpha toxin and other projects; 3) 2* The 1000L-scale bioreactor FlexFactory™ commercial production line was officially put into operation.
Among them, TNM002 is a new generation of monoclonal antibody drugs industrially produced by Technolab using genetic recombination technology.
Dr.
Mr.